PGR
69
4
PVH
52
2
TEL
60
3
DUK
69
5
FOX
33
3
EXPE
72
8
AEP
66
2
ED
58
2
EQT
57
15
RL
65
3
KMX
47
3
VRTX
62
5
SRE
54
5
MLM
50
3
OKE
70
3
SE
65
4
PPG
64
4
KHC
49
4
HSIC
51
6
M
12
6
PGR
69
4
PVH
52
2
TEL
60
3
DUK
69
5
FOX
33
3
EXPE
72
8
AEP
66
2
ED
58
2
EQT
57
15
RL
65
3
KMX
47
3
VRTX
62
5
SRE
54
5
MLM
50
3
OKE
70
3
SE
65
4
PPG
64
4
KHC
49
4
HSIC
51
6
M
12
6
Financhill
Back

Cartesian Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
37

RNAC
Cartesian Therapeutics

Last Price:
16.33
Seasonality Move:
-14.99%
Sell
25

ALNY
Alnylam Pharmaceuticals

Last Price:
270.41
Seasonality Move:
5.61%
Sell
37
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $16.75. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $265.27. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $16.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $265.27
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 60.37 Buy
Chaikin Money Flow: 26939 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.19 - 15.15) Buy
Bollinger Bands (100): (14.16 - 27.02) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 53.6 Buy
Chaikin Money Flow: 403934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (256.2 - 277.22) Sell
Bollinger Bands (100): (158.9 - 265.08) Buy

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.63 Buy
20-day SMA: 14.35 Buy
50-day SMA: 15.28 Buy
200-day SMA: 20.86 Sell
8-day EMA: 15.15 Buy
20-day EMA: 14.69 Buy
50-day EMA: 16.18 Buy
200-day EMA: 21.88 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 256.17 Buy
20-day SMA: 266.77 Sell
50-day SMA: 258.27 Buy
200-day SMA: 189.51 Buy
8-day EMA: 260.57 Buy
20-day EMA: 261.96 Buy
50-day EMA: 250.03 Buy
200-day EMA: 205.35 Buy

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):